Lohia Corp IPO GMP Today

Live GMP Mainboard

Live Grey Market Premium today

Current Grey Market Premium
+₹40 (9.41%)

Premium: ₹40 🚀

Expected Listing Price
MetricValue
Issue Price (Upper Band)₹425
Current GMP₹40 (9.41%)
Expected Listing Price₹465
Listing Gain per Lot₹1400

GMP is unofficial and can change rapidly. Do not rely solely on GMP for investment decisions.

Price Band
₹404 to ₹425
Lot Size
35 Shares
Issue Size
₹1,101.28 Cr
Subscription
Active
Min Investment
₹14,875
GMP
+₹40 (9.41%)
Aggregated public data · Updated 22 Jul 2026, 9:39 am. GMP is unofficial and can change quickly.
Verify source: Public issue sources
Open
Jul 23, 2026
Close
Jul 27, 2026
AllotmentT
Jul 28, 2026
ListingT
Jul 30, 2026
Subscription Status
CategorySubscriptionDemand
Overall Active 📉 Low

Category-wise breakdowns are updated as data becomes available from exchanges.

Share GMP Data
हिंदी में जानकारी

Lohia Corp IPO GMP आज: Grey Market Premium +₹40 (9.41%) है। इसका मतलब है कि unofficial market में शेयर ₹40 के premium पर trade हो रहे हैं। Expected listing price ₹465 है। ध्यान रखें कि GMP unofficial है और बदल सकता है।

Frequently Asked Questions
Lohia Corp IPO Grey Market Premium (GMP) is currently +₹40 (9.41%). This indicates the premium at which IPO shares are trading in the unofficial grey market before listing.
Based on current GMP of +₹40 (9.41%), the expected listing price of Lohia Corp IPO is approximately ₹465 per share (Issue price ₹425 + GMP ₹40).
GMP is an unofficial indicator from the grey market and should not be the sole basis for investment decisions. It reflects market sentiment but actual listing price may differ significantly. Always consider fundamentals and financials.
Lohia Corp IPO subscription status is Active. Total subscription times indicate overall demand from Retail, HNI, and QIB investors.
While a positive GMP indicates good market sentiment, investment decisions should also consider company fundamentals, financials, peer comparison, and your risk appetite. GMP alone is not sufficient for making investment decisions.
More About This IPO